DK0519218T3 - Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein - Google Patents

Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein

Info

Publication number
DK0519218T3
DK0519218T3 DK92108254T DK92108254T DK0519218T3 DK 0519218 T3 DK0519218 T3 DK 0519218T3 DK 92108254 T DK92108254 T DK 92108254T DK 92108254 T DK92108254 T DK 92108254T DK 0519218 T3 DK0519218 T3 DK 0519218T3
Authority
DK
Denmark
Prior art keywords
kda
coli
antigen
kda antigen
host
Prior art date
Application number
DK92108254T
Other languages
Danish (da)
English (en)
Inventor
Mahavir Dr Singh
Kenneth Prof Dr Timmis
Original Assignee
Biotechnolog Forschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnolog Forschung Gmbh filed Critical Biotechnolog Forschung Gmbh
Application granted granted Critical
Publication of DK0519218T3 publication Critical patent/DK0519218T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92108254T 1991-05-17 1992-05-15 Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein DK0519218T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116249A DE4116249A1 (de) 1991-05-17 1991-05-17 Hybrid-plasmid fuer m.-tuberculosis-antigen, e. coli als wirt und antigen

Publications (1)

Publication Number Publication Date
DK0519218T3 true DK0519218T3 (da) 1999-08-02

Family

ID=6431926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92108254T DK0519218T3 (da) 1991-05-17 1992-05-15 Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein

Country Status (8)

Country Link
US (1) US6110469A (xx)
EP (1) EP0519218B1 (xx)
JP (1) JPH05344894A (xx)
AT (1) ATE173506T1 (xx)
DE (2) DE4116249A1 (xx)
DK (1) DK0519218T3 (xx)
ES (1) ES2125873T3 (xx)
NZ (1) NZ242757A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1997041252A2 (en) * 1996-04-29 1997-11-06 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Dna, rna and a protein useful for detection of a mycobacterial infection
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US7087713B2 (en) 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
US8143386B2 (en) 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO2001024820A1 (en) 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2001098460A2 (en) 2000-06-20 2001-12-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
WO2003070187A2 (en) 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
ITPR20040015A1 (it) * 2004-02-24 2004-05-24 Niro Soavi Spa Procedimento e apparato per la rottura cellulare in una sospensione fluida in continuo.
CN100350048C (zh) * 2005-07-21 2007-11-21 复旦大学 一种重组卡介苗及其制备方法
CN100457912C (zh) * 2005-07-21 2009-02-04 复旦大学 重组Ag85B卡介苗
EP2453914B1 (en) 2009-07-16 2018-09-05 Vaxil Biotherapeutics Ltd. Antigen specific multi epitope -based anti-infective vaccines

Also Published As

Publication number Publication date
US6110469A (en) 2000-08-29
JPH05344894A (ja) 1993-12-27
EP0519218B1 (de) 1998-11-18
ES2125873T3 (es) 1999-03-16
DE4116249A1 (de) 1992-11-19
ATE173506T1 (de) 1998-12-15
NZ242757A (en) 1993-09-27
EP0519218A2 (de) 1992-12-23
EP0519218A3 (en) 1993-10-20
DE59209560D1 (de) 1998-12-24

Similar Documents

Publication Publication Date Title
DK0519218T3 (da) Hybridplasmid for 38 kDa-antigenet fra M. tuberculosis, E. coli som vært, 38 kDa-antigenet og et ca. 33 kDa-protein
DK1047784T3 (da) Neissera meningitidis-antigener
DK0776209T3 (da) Polynukleinsyrer og proteiner fra et porcin reproduktiv og respiratorisk syndrom-virus og anvendelser deraf
NO960839L (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse
DK0634490T3 (da) Xylanase afledt fra en bacillusart, udtrykkelsesvektorer for sådan en xylanase og andre proteiner, værtsorganismer derfor og anvendelse deraf
DE69841807D1 (de) Neisseriale antigene
TR25270A (tr) Ikameli ftalitler ve heterosiklik ftalitler
DK0598816T3 (da) Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner
DE68929467D1 (de) HIV-2 Varianten
AU7607891A (en) Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
EP0379549A4 (en) Endotoxin binding protein and uses thereof
NO974322L (no) DNA som koder for human papillomvirus type 18
FI882444A0 (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE69211161D1 (de) Antibiotische 7-aminonaphthazarinderivate
ZA916106B (en) Cloning and expression of a rhoptry-associated protein of p.falciparum
ATA211388A (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen